GlassScriptPhysician profile
Tyler Nicholson
NPI 1205356482
$6,908.61
in general payments reported to CMS, 2019-2025
13 companies · $1,962 in 2025
The $1,962 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $34.42 · 2022: $1,529 · 2023: $2,842 · 2024: $540 · 2025: $1,962.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,462 · Food and Beverage: $1,883.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,461.66 |
| Food and Beverage | $1,883.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $5,567.13 | 2022-2025 | Mako, Accolade, Insignia |
| Zimmer Biomet Holdings, INC. | $514.11 | 2023-2024 | Rosa, Persona |
| Si-Bone, INC. | $239.88 | 2022-2024 | |
| Orthalign INC | $164.67 | 2023 | Orthalign Plus |
| Embody, INC. | $102.46 | 2023 | |
| Innovation Technologies INC | $85.59 | 2023 | Irrisept |
| Rattan and Associates | $79.88 | 2022 | |
| Linvatec Corporation | $51.59 | 2023 | Biobrace 23mm |
| Bioventus LLC | $24.65 | 2023 | |
| Pacira Pharmaceuticals Incorporated | $23.18 | 2022 | |
| Csl Behring | $23.01 | 2019 | |
| Kci USA, INC. | $21.05 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $11.41 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tyler Nicholson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.